Studying aHUS in Egyptian patients
Part of Blood & lymphatic, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks back at medical records of people with a blood clotting disorder (TMA) to better understand a rare type called aHUS in Egypt. It may help doctors learn how to diagnose and treat this condition more effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least one month old.
- You must be male or female of any age as long as you are at least one month old.
- You must have been diagnosed with TMA (a condition where small blood clots form in your blood vessels) between January 1, 2010 and December 31, 2023.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how rare gene mutations may explain atypical HUS (aHUS) and how that could guide more personalized treatment. It mainly involves people who have had aHUS affecting blood counts and kidneys.
This is a registry that collects information from people diagnosed with atypical hemolytic uremic syndrome (aHUS). It helps researchers better understand the condition across different genetic causes and treatment needs.
This trial tests the drug ravulizumab for people with aHUS (a rare blood and kidney condition). It aims to see if the drug can help improve blood counts and kidney function.
This study follows people with aHUS who are already taking iptacopan to check how well it continues to work and how safe it is over the long term. You may be asked to keep taking the study medicine and follow extra safety rules, including infection and pregnancy precautions.
This trial tests whether people with atypical hemolytic uremic syndrome (aHUS) who are doing well on anti-C5 treatment can safely switch to iptacopan. It focuses on both effectiveness (blood counts and kidney function) and safety after the switch.
This study looks at how people with hereditary angioedema (HAE) are diagnosed and treated in Egypt. It may help doctors better understand and care for this condition.
Hear when a new Atypical Hemolytic Uremic Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.